Treatment and prevention of ocular neurodegenerative disorder
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 19, 2022
Grant Date -
Dec 6, 2018
app pub date -
Apr 23, 2018
filing date -
Oct 23, 2015
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The invention relates to the use of a pharmaceutical composition containing nicotinamide (NAM) and/or pyruvate as a neuroprotective medicament or gene therapy in the treatment of neurodegenerative disorders, in particular axon degeneration of neuronal tissue in ocular-related neurodegeneration diseases including glaucoma.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 3 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Jan 19, 2026 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Jan 19, 2030 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jan 19, 2034 |
